Overview

Ex Vivo Human Thrombosis Chamber Study

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Purpose of study is to evaluate a thrombosis chamber model
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Aspirin
Clopidogrel